全文获取类型
收费全文 | 28626篇 |
免费 | 1882篇 |
国内免费 | 355篇 |
专业分类
耳鼻咽喉 | 593篇 |
儿科学 | 302篇 |
妇产科学 | 445篇 |
基础医学 | 4982篇 |
口腔科学 | 646篇 |
临床医学 | 2254篇 |
内科学 | 5085篇 |
皮肤病学 | 987篇 |
神经病学 | 2345篇 |
特种医学 | 1960篇 |
外科学 | 4034篇 |
综合类 | 102篇 |
现状与发展 | 3篇 |
一般理论 | 12篇 |
预防医学 | 1002篇 |
眼科学 | 837篇 |
药学 | 2706篇 |
中国医学 | 351篇 |
肿瘤学 | 2217篇 |
出版年
2023年 | 148篇 |
2022年 | 113篇 |
2021年 | 971篇 |
2020年 | 512篇 |
2019年 | 795篇 |
2018年 | 962篇 |
2017年 | 736篇 |
2016年 | 1105篇 |
2015年 | 1537篇 |
2014年 | 1752篇 |
2013年 | 1945篇 |
2012年 | 2925篇 |
2011年 | 2695篇 |
2010年 | 1668篇 |
2009年 | 1410篇 |
2008年 | 1780篇 |
2007年 | 1787篇 |
2006年 | 1575篇 |
2005年 | 1317篇 |
2004年 | 1066篇 |
2003年 | 941篇 |
2002年 | 774篇 |
2001年 | 515篇 |
2000年 | 425篇 |
1999年 | 303篇 |
1998年 | 132篇 |
1997年 | 105篇 |
1996年 | 63篇 |
1995年 | 70篇 |
1994年 | 51篇 |
1993年 | 55篇 |
1992年 | 81篇 |
1991年 | 74篇 |
1990年 | 70篇 |
1989年 | 57篇 |
1988年 | 47篇 |
1987年 | 50篇 |
1986年 | 27篇 |
1985年 | 24篇 |
1984年 | 20篇 |
1983年 | 14篇 |
1982年 | 9篇 |
1981年 | 21篇 |
1980年 | 10篇 |
1979年 | 20篇 |
1978年 | 16篇 |
1977年 | 15篇 |
1976年 | 16篇 |
1975年 | 12篇 |
1970年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 111 毫秒
1.
2.
3.
So Young Jeon Oh Eun Kwon Jin Woo Jang Sang Yoon Kang Jin-Young Min Sung Wan Kim 《Auris, nasus, larynx》2021,48(5):1031-1034
Stickler syndrome is a genetic disorder of connective tissue. One of the major symptoms associated with this disorder is an oro-facial malformation, which may cause a submucous cleft or a complete cleft of the hard palate. A 32-year-old man diagnosed with Stickler syndrome and a submucosal cleft palate (SMCP) visited our hospital with a chief complaint of excessive daytime sleepiness. The patient was diagnosed with severe obstructive sleep apnea (OSA), and administration of a polysomnography test revealed an apnea-hypopnea index (AHI) of 30.9 events/hour (h). Auto-titrating continuous positive airway pressure was initiated to control the OSA symptoms and subsequently the patient showed some improvement. However, due to continuous velopharyngeal insufficiency symptoms, intravelar veloplasty was performed. Three months after surgery, the AHI had decreased to 12.4 events/h. Recent studies have described a greater risk for OSA in individuals with cleft palate, than in the general population. The present case demonstrates surgical success in a patient with OSA and SMCP, suggesting that palatal surgery may be considered an optional surgical treatment for OSA patients with SMCP. 相似文献
4.
5.
6.
Min Hee Hong MD Seong Gu Heo PhD Yun-Gyoo Lee MD PhD Hyo Song Kim MD PhD Keon Uk Park MD PhD Hoon-Gu Kim MD PhD Yoon Ho Ko MD PhD Ik-Joo Chung MD PhD Young Joo Min MD PhD Min Kyoung Kim MD PhD Kyu Ryung Kim PhD Jinseon Yoo MS Tae-Min Kim MD PhD Hye Ryun Kim MD PhD Byoung Chul Cho MD PhD 《Cancer》2020,126(20):4521-4531
7.
Pancreatic cancer, a highly lethal cancer, has the lowest 5-year survival rate for several reasons, including its tendency for the late diagnosis, a lack of serologic markers for screening, aggressive local invasion, its early metastatic dissemination, and its resistance to chemotherapy/radiotherapy. Pancreatic cancer evades immunologic elimination by a variety of mechanisms, including induction of an immunosuppressive microenvironment. Cancer-associated fibroblasts interact with inhibitory immune cells, such as tumor-associated macrophages and regulatory T cells, to form an inflammatory shell-like desmo plastic stroma around tumor cells. Immunotherapy has the potential to mobilize the immune system to eliminate cancer cells. Nevertheless, although immunotherapy has shown brilliant results across a wide range of malignancies, only anti-programmed cell death 1 antibodies have been approved for use in patients with pancreatic cancer who test positive for microsatellite instability or mismatch repair deficiency. Some patients treated with immunotherapy who show progression based on conventional response criteria may prove to have a durable response later. Continuation of immune-based treatment beyond disease progression can be chosen if the patient is clinically stable. Immunotherapeutic approaches for pancreatic cancer treatment deserve further exploration, given the plethora of combination trials with other immunotherapeutic agents, targeted therapy, stroma-modulating agents, chemotherapy, and multi-way combination therapies. 相似文献
8.
Byung-Ho Yoon Lynne C. Jones Chung-Hwan Chen Edward Y. Cheng Quanjun Cui Wolf Drescher Wakaba Fukushima Valerie Gangji Stuart B. Goodman Yong-Chan Ha Philippe Hernigou Marc Hungerford Richard Iorio Woo-Lam Jo Vikas Khanduja Harry Kim Shin-Yoon Kim Tae-Young Kim Kyung-Hoi Koo 《The Journal of arthroplasty》2019,34(1):169-174.e1
Background
Although alcohol is a leading risk factor for osteonecrosis of the femoral head (ONFH) and its prevalence reportedly ranges from 20% to 45%, there are no unified classification criteria for this subpopulation. In 2015, Association Research Circulation Osseous decided to develop classification criteria for alcohol-associated ONFH.Methods
In June of 2017, Association Research Circulation Osseous formed a task force to conduct a Delphi survey. The task force invited 28 experts in osteonecrosis/bone circulation from 8 countries. Each round of the Delphi survey included questionnaires, analysis of replies, and feedback reports to the panel. After 3 rounds of the survey, consensus was reached on the classification criteria. The response rates for the 3 Delphi rounds were 100% (round 1), 96% (round 2), and 100% (round 3).Results
The consensus on the classification criteria of alcohol-associated ONFH included the following: (1) patients should have a history of alcohol intake >400 mL/wk (320 g/wk, any type of alcoholic beverage) of pure ethanol for more than 6 months; (2) ONFH should be diagnosed within 1 year after alcohol intake of this dose; and (3) patients should not have other risk factor(s).Conclusion
ARCO-established classification criteria to standardize clinical studies concerning AA-ONFH. 相似文献9.
10.